Status:
RECRUITING
Pediatric Pertussis in Ambulatory Settings
Lead Sponsor:
Association Clinique Thérapeutique Infantile du val de Marne
Collaborating Sponsors:
GlaxoSmithKline
Sanofi
Conditions:
Pertussis/Whooping Cough
Children, Only
Eligibility:
All Genders
1-18 years
Brief Summary
Since 2002, Whooping cough surveillance in pediatric private practice has been set up in France. The results of the first years, 2002-2006, have confirmed the effectiveness of the Pertussis whole-cell...
Detailed Description
The whooping cough surveillance objectives are : * to follow the duration of protection of the Ca vaccines in the context of modifications of the vaccine recommendations * to describe the clinical ch...
Eligibility Criteria
Inclusion
- All children under 18 years old with a pertussis diagnosis is suspected and a biological exam is requested
Exclusion
- children without symptoms with a household confirmed case
- cases for which the pertussis diagnosis was not suspected by the pediatrician
Key Trial Info
Start Date :
May 30 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
898 Patients enrolled
Trial Details
Trial ID
NCT04807712
Start Date
May 30 2001
End Date
January 1 2030
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ACTIV
Créteil, France, 94000